Acurx Pharmaceuticals, Inc. Common Stock (ACXP) is a publicly traded Healthcare sector company. As of October 21, 2026, ACXP trades at $1.17 with a market cap of $4.90M and a P/E ratio of -0.24. ACXP moved +0.00% today. Year to date, ACXP is -58.70%; over the trailing twelve months it is -83.64%. Its 52-week range spans $1.07 to $21.00. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces ACXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ACXP combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.17 |
| Market Cap | $4.90M |
| P/E Ratio | -0.24 |
| EPS | $-5.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.00 |
| 52-Week Low | $1.07 |
| Volume | 3.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.97M |
| Gross Margin | 0.00% |
3 analysts cover ACXP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.